Immunome, Inc. logo

Immunome, Inc.

Transformative Targeted Therapies

246 employees · est. 2008 · Bothell, United States

VS
MimiVax, Inc. logo

MimiVax, Inc.

Disrupting Cancer with Immunotherapy

3 employees · est. 2012 · Buffalo, United States

Immunome, Inc. is the older company (2008 vs 2012); Immunome, Inc. is the larger of the two.

Side-by-Side Comparison

Immunome, Inc. MimiVax, Inc.
Founded
2008 older 2012
Headquarters
Bothell, United States Buffalo, United States
Employees
246 larger 3
Industry
Biopharma, Biotechnology, Pharmaceutical Biopharma, Biotechnology, Pharmaceutical
Funding Stage
IPO Series Unknown
Total Funding
$1.02B $16.55M
Funding Rounds
18 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Antibody-based Therapeutics, Immunotherapy, Cancer, Immune System, Discovery Engine, Antigens, High-content Screening, Therapeutic Potential Immunotherapy, Cancer Treatment, Clinical-stage Company, Immunotherapeutic Vaccines, Targeted Therapies, Survivin-targeting Technology, Glioblastoma, Multiple Myeloma, Neuro-Endocrine Tumors, Pediatric High Grade Glioma, Medulloblastoma, DIPG, Oncology, Pharmaceutical Development
Website
immunome.com mimivax.com
Immunome, Inc. logo

About Immunome, Inc.

Immunome, Inc. is a biotechnology company focused on developing antibody-based therapeutics by unlocking the human memory B cell response. Founded in 2008 and headquartered in the United States, the company has a growing pipeline of cancer immunotherapies fueled by the human immune system. Immunome'...

MimiVax, Inc. logo

About MimiVax, Inc.

MimiVax, Inc. is a privately held, clinical-stage biotechnology company founded in 2012 with a vision to disrupt cancer through highly innovative immunotherapies. The company's lead immunotherapeutic vaccine, , has shown promise by completing a Phase 2a clinical trial in adults with newly diagnosed...

We will tell you when either one moves

BounceWatch watches Immunome, Inc. and MimiVax, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Immunome, Inc. and MimiVax, Inc. — by email.

Frequently Asked Questions

Immunome, Inc. — Transformative Targeted Therapies. MimiVax, Inc. — Disrupting Cancer with Immunotherapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Immunome, Inc. has raised $1.02B while MimiVax, Inc. has raised $16.55M.
Immunome, Inc. and MimiVax, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Immunome, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Immunome, Inc. on 9 Jun 2026, and MimiVax, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy